Human M2e peptide immunogens

Details for Australian Patent Application No. 2009314091 (hide)

Owner Theraclone Sciences, Inc.

Inventors Mitcham, Jennifer; Moyle, Matthew

Agent Cullens

Pub. Number AU-A-2009314091

PCT Pub. Number WO2010/056796

Priority 61/113,880 12.11.08 US

Filing date 12 November 2009

Wipo publication date 20 May 2010

International Classifications

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/056796 Priority application(s): WO2010/056796

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314099-Antibody formulation

2009314084-Gaseous fuel engine charge density control system